Mika Nishimura
Director/Board Member presso SI-BONE, INC.
Patrimonio netto: 702 218 $ in data 31/03/2024
Profilo
Mika Nishimura is the founder of BLG Group.
She currently holds four positions as an independent director at SI-BONE, Inc., HOYA Corp., Accuray, Inc., and MobileODT Ltd.
Previously, she held positions as Director-Global Marketing at Guidant Vascular Intervention, VP-International Sales, Operations & Marketing at ev3, Inc., Vice President-Commercialization at nVision Medical Corp., and Vice President-Commercial Development at Auxogyn, Inc. She received her undergraduate degree from Yale University and her MBA from Harvard Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ACCURAY INCORPORATED
0.16% | 30/11/2023 | 156 056 ( 0.16% ) | 385 458 $ | 31/03/2024 |
SI-BONE, INC.
0.05% | 13/03/2024 | 19 350 ( 0.05% ) | 316 760 $ | 31/03/2024 |
Posizioni attive di Mika Nishimura
Società | Posizione | Inizio |
---|---|---|
SI-BONE, INC. | Director/Board Member | 04/03/2021 |
ACCURAY INCORPORATED | Director/Board Member | 17/08/2021 |
HOYA CORPORATION | Director/Board Member | 01/06/2022 |
BLG Group | Founder | - |
MobileODT Ltd.
MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Director/Board Member | - |
Precedenti posizioni note di Mika Nishimura
Società | Posizione | Fine |
---|---|---|
nVision Medical Corp.
nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2020 |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01/01/2015 |
Guidant Vascular Intervention | Sales & Marketing | - |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Chief Operating Officer | - |
Formazione di Mika Nishimura
Yale University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
SI-BONE, INC. | Health Technology |
HOYA CORPORATION | Health Technology |
ACCURAY INCORPORATED | Health Technology |
Aziende private | 6 |
---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
nVision Medical Corp.
nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Health Services |
Guidant Vascular Intervention | |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
BLG Group | |
MobileODT Ltd.
MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Technology Services |
- Borsa valori
- Insiders
- Mika Nishimura